He Zhang

Shanghai, 200092, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Targeted OUM1/PTPRZ1 silencing and synergetic CDT/enhanced chemical therapy toward uveal melanoma based on a dual-modal imaging-guided manganese metal-organic framework nanoparticles.

Targeted OUM1/PTPRZ1 silencing and synergetic CDT/enhanced chemical therapy toward uveal melanoma based on a dual-modal imaging-guided manganese metal-organic framework nanoparticles.

Journal: Journal of nanobiotechnology

Published: July 10, 2022

A novel LncRNA transcript, RBAT1, accelerates tumorigenesis through interacting with HNRNPL and cis-activating E2F3.

A novel LncRNA transcript, RBAT1, accelerates tumorigenesis through interacting with HNRNPL and cis-activating E2F3.

Journal: Molecular cancer

Published: November 26, 2019

Dynamic chromosomal tuning of a novel GAU1 lncing driver at chr12p13.32 accelerates tumorigenesis.

Dynamic chromosomal tuning of a novel GAU1 lncing driver at chr12p13.32 accelerates tumorigenesis.

Journal: Nucleic acids research

Published: January 06, 2018

The miR-181 family promotes cell cycle by targeting CTDSPL, a phosphatase-like tumor suppressor in uveal melanoma.

The miR-181 family promotes cell cycle by targeting CTDSPL, a phosphatase-like tumor suppressor in uveal melanoma.

Journal: Journal of experimental & clinical cancer research : CR

Published: October 11, 2017

Novel insights into chromosomal conformations in cancer.

Novel insights into chromosomal conformations in cancer.

Journal: Molecular cancer

Published: April 27, 2017

The Long Non-Coding RNA RHPN1-AS1 Promotes Uveal Melanoma Progression.

The Long Non-Coding RNA RHPN1-AS1 Promotes Uveal Melanoma Progression.

Journal: International journal of molecular sciences

Published: December 30, 2016

CANT1 lncRNA Triggers Efficient Therapeutic Efficacy by Correcting Aberrant lncing Cascade in Malignant Uveal Melanoma.

CANT1 lncRNA Triggers Efficient Therapeutic Efficacy by Correcting Aberrant lncing Cascade in Malignant Uveal Melanoma.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: October 27, 2016

Targeted silencing of the ADP-ribosyltransferase 3 gene inhibits the migration ability of melanoma cells.

Targeted silencing of the ADP-ribosyltransferase 3 gene inhibits the migration ability of melanoma cells.

Journal: Oncology letters

Published: June 12, 2016

PAUPAR lncRNA suppresses tumourigenesis by H3K4 demethylation in uveal melanoma.

PAUPAR lncRNA suppresses tumourigenesis by H3K4 demethylation in uveal melanoma.

Journal: FEBS letters

Published: March 16, 2016

HIC1 modulates uveal melanoma progression by activating lncRNA-numb.

HIC1 modulates uveal melanoma progression by activating lncRNA-numb.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: March 13, 2016

ANRIL lncRNA triggers efficient therapeutic efficacy by reprogramming the aberrant INK4-hub in melanoma.

ANRIL lncRNA triggers efficient therapeutic efficacy by reprogramming the aberrant INK4-hub in melanoma.

Journal: Cancer letters

Published: February 15, 2016

Novel Insights into the Role of Long Noncoding RNA in Ocular Diseases.

Novel Insights into the Role of Long Noncoding RNA in Ocular Diseases.

Journal: International journal of molecular sciences

Published: February 11, 2016

Showing 1-12 of 18

Last Updated: 09/26/2026